Inhaled Gene Therapy in Lung Cancer: “as for the future, Our Task is Not to Foresee it, But to Enable it”
- 23 August 2012
- journal article
- Published by Taylor & Francis in Therapeutic Delivery
- Vol. 3 (8) , 919-921
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Feasibility and effectiveness of inhaled carboplatin in NSCLC patientsInvestigational New Drugs, 2011
- Chitosan–interferon-β gene complex powder for inhalation treatment of lung metastasis in miceJournal of Controlled Release, 2011
- Aerosol delivery of kinase-deficient Akt1 attenuates Clara cell injury induced by naphthalene in the lungs of dual luciferase miceJournal of Veterinary Science, 2011
- Drug transporters in the lung—do they play a role in the biopharmaceutics of inhaled drugs?Journal of Pharmaceutical Sciences, 2010
- Enhanced Lung Gene Expression After Aerosol Delivery of Concentrated pDNA/PEI ComplexesMolecular Therapy, 2008
- Toward Therapies Tailored to Patient CharacteristicsJournal of Thoracic Oncology, 2007
- Phase I Study of Aerosolized SLIT Cisplatin in the Treatment of Patients with Carcinoma of the LungClinical Cancer Research, 2007
- Pulmonary drug delivery. Part I: Physiological factors affecting therapeutic effectiveness of aerosolized medicationsBritish Journal of Clinical Pharmacology, 2003
- Pulmonary drug delivery. Part II: The role of inhalant delivery devices and drug formulations in therapeutic effectiveness of aerosolized medicationsBritish Journal of Clinical Pharmacology, 2003
- Gene delivery by an epidermal growth factor/DNA polyplex to small cell lung cancer cell lines expressing low levels of epidermal growth factor receptorCancer Gene Therapy, 2000